VOR Competitors & Alternatives
Compare Vor Biopharma Inc with similar stocks in the same industry
Biotechnology
VOR
Main Stock$19.26
-0.82%
Tradestie Score
58
Market Cap
$269.08M
P/E Ratio
0.1
Analyst Upside
+102.5%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Cell Therapy
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
-0.21%
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
+0.82%
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$4.33
-4.63%
|
$1.18B | 42.4 | 60 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$47.74
-2.18%
|
$1.17B | - | 34 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$18.59
-2.34%
|
$1.15B | 8.1 | 54 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$13.30
-2.56%
|
$1.14B | - | 42 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$7.69
-2.23%
|
$1.14B | - | 45 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$34.16
-0.50%
|
$1.13B | - | 32 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$2.89
-7.82%
|
$1.12B | - | 32 | Compare |
|
NKTR
Nektar Therapeutics
|
$36.57
-1.88%
|
$1.12B | - | 59 | Compare |
More VOR Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)
216 stocks in this industry